The Ig fold of the core binding factor α Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains  by Berardi, Marcelo J et al.
The Ig fold of the core binding factor α Runt domain is a member
of a family of structurally and functionally related Ig-fold
DNA-binding domains
Marcelo J Berardi1, Chaohong Sun1, Michael Zehr1, Frits Abildgaard2,
Jeff Peng3, Nancy A Speck4 and John H Bushweller1*
Background: CBFA is the DNA-binding subunit of the transcription factor
complex called core binding factor, or CBF. Knockout of the Cbfa2 gene in
mice leads to embryonic lethality and a profound block in hematopoietic
development. Chromosomal disruptions of the human CBFA gene are
associated with a large percentage of human leukemias. 
Results: Utilizing nuclear magnetic resonance spectroscopy we have
determined the three-dimensional fold of the CBFA Runt domain in its
DNA-bound state, showing that it is an s-type immunoglobulin (Ig) fold. DNA
binding by the Runt domain is shown to be mediated by loop regions located at
both ends of the Runt domain Ig fold. A putative site for CBFB binding has
been identified; the spatial location of this site provides a rationale for the ability
of CBFB to modulate the affinity of the Runt domain for DNA. 
Conclusions: Structural comparisons demonstrate that the s-type Ig fold found
in the Runt domain is conserved in the Ig folds found in the DNA-binding
domains of NF-κB, NFAT, p53, STAT-1, and the T-domain. Thus, these proteins
form a family of structurally and functionally related DNA-binding domains.
Unlike the other members of this family, the Runt domain utilizes loops at both
ends of the Ig fold for DNA recognition.
Introduction
Core binding factors (CBFs) are heterodimeric transcription
factors consisting of a DNA-binding subunit (CBFA) and a
non-DNA-binding subunit (CBFB) [1–4]. All CBFA sub-
units share a region of homology known as the Runt domain,
which is the DNA-binding domain of these proteins [2,4,5].
CBFs are global developmental regulators in both Drosophila
and mammals. The Drosophila Runt gene, the founding
member of the CBFA family, is required for sex determina-
tion, segmentation, and neurogenesis. The mammalian
CBFA1 gene is required for bone development [6]. CBFA2
(AML1) and CBFB, which encode the CBFA and CBFB
subunits, respectively, are essential for the emergence of all
fetal and adult blood cell lineages in the mammalian embryo
[7,8]. An in vivo function for a third mammalian CBFA gene,
CBFA3, is currently unknown. Mutations in the CBF genes
are also associated with human disease. Chromosomal
rearrangements involving CBFA2 [t(8;21)(q22;q22),
t(12;21)(p13;q22)], t(3;21)(q26;q22), t(16;21)(q24;q22),
t(1;21)(p36;q22), t(5;21)(q13;q22), t(12;21)(q24;q22),
t(14;21)(q22;q22), t(15;21)(q22;q22), t(17;21)(q11.2;q22)]
and CBFB [inv(16)(p13;q22)] are found in a large
number of myeloid and lymphocytic leukemias [9]. 
The CBFB subunit interacts with the Runt domain of the
CBFA subunit, increasing its affinity for DNA approxi-
mately sixfold [3] (BE Crute et. al., unpublished results).
CBFB modulates the DNA-binding affinity of the Runt
domain without establishing additional contacts to the
DNA [4]. Circular dichroism (CD) spectroscopy docu-
mented a conformational change in either or both the
Runt domain and the CBFB subunit upon heterodimer-
ization (BE Crute et al., unpublished results). The data
support a model whereby heterodimerization with the
CBFB subunit ‘locks in’ a high-affinity DNA-binding con-
formation of the Runt domain. Genetic data clearly
demonstrate that heterodimerization with the CBFB
subunit is essential for CBFA function in vivo, in that
homozygous disruption of the Cbfa2 and Cbfb genes in
mice results in identical phenotypes.
The primary sequence of the Runt domain shows no
homology to any of the known DNA-binding motifs.
The mechanism by which CBFB stabilizes the
CBFA–DNA complex is unusual in that contacts to the
DNA are not substantially altered. A predicted model of
the structure of the Runt domain has been described
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[10], but no structural data has yet been presented on
this functionally important domain. We recently
presented the high-resolution structure of the CBFB
protein [11]. Here we describe the fold of the 
DNA-bound CBFA2 Runt domain in solution, demon-
strate its structural similarity to the DNA-binding
domains of the eukaryotic transcription factors NF-κB,
NFAT, STAT-1, and p53, and identify the DNA- and 
CBFB-binding sites. 
Results
Choice of construct and backbone resonance assignments
The Runt domain was first identified from a 128 amino
acid region of extremely high homology (92% identity)
observed between the human CBFA2 (AML1) and the
Drosophila Runt proteins. Subsequent deletion-mutagene-
sis experiments showed that this domain is responsible for
both DNA and CBFB binding. We previously character-
ized a Runt domain fragment of the murine CBFA2 protein
spanning residues 41–190 (numbered from CBFA2/p49, or
PEBP2aB1 according to Bae et al. [12]), that included the
Runt homology region [13] (residues 51–178). Sedimenta-
tion-equilibrium measurements on this protein showed it
to have a pronounced tendency to aggregate (data not
shown). We therefore explored the ability of additional N-
and C-terminal sequences to improve the solution behavior
of the protein. A construct spanning residues 41–214 was
found to be predominantly monomeric at modest concen-
trations (~50 µM); however, it was soluble only as a
complex with DNA. Therefore all studies have been
carried out on a complex of CBFA2(41–214) and an 18 base
pair DNA molecule containing a high-affinity core site
[14,15]. Even under these conditions, the complex has a
limited solubility, and we have only been able to prepare
~0.5 mM solutions for nuclear magnetic resonance (NMR)
spectroscopy. Interestingly, the 41–214 protein loses most
of the additional C-terminal residues after prolonged mea-
surement times, yielding a protein spanning residues
41–192 according to N-terminal sequencing and matrix-
assisted laser desorption ionization (MALDI) mass spectral
analysis (data not shown). 
All NMR data were recorded at 40°C. A sample of 50%
2H/98% 13C, 15N-labeled Runt domain complexed to
DNA was utilized to collect three-dimensional (3D)
HNCACB, HNCOCACB, HN(CA)CO, and 15N-edited
nuclear Overhauser efffect spectroscopy (NOESY) data
at 750 MHz at the National Magnetic Resonance Facility
at Madison (NMRFAM). These spectra yielded the
majority of the backbone assignments; however, reso-
nance assignments were not obtained for a number of
residues and regions of the protein where apparent
exchange broadening limited the quality of triple-reso-
nance data. In order to obtain assignments for these
residues and complete the assignments, we prepared
samples specifically 15N-labeled for the amino acids Ala,
Arg, Cys, His, Ile, Leu, Lys, Phe, Thr, Trp, Tyr, and Val
using auxotrophs for the various amino acids [16]. In
addition, we recorded HNCA and HN(CA)CB spectra on
a sample of 98% 2H,13C,15N-labeled Runt domain at
500 MHz, which provided additional triple-resonance
correlations not obtained previously. HNCO spectra on
this sample provided CO chemical shifts for the calcula-
tions with the program TALOS (see below). On the basis
of this data we have obtained at least partial assignments
for all residues except Ala1, Ser2, Pro116, Arg124,
Gly132, Arg170, Pro173 and His174. HN, N, CA, and CB
chemical-shift assignments have been obtained for 161 of
the 174 amino acids in this Runt-domain fragment. In
order to identify elements of secondary structure and
protein–DNA NOEs, a 3D 15N-edited NOESY spectrum
was recorded on this sample at 800 MHz. Amino acid 1 of
our Runt-domain fragment begins at amino acid 41 in
CBFA2/p49 (AML1b, PEBP2aB1 [12]). 
Collection of conformational constraints and calculation of
the 3D structure
It has recently been very elegantly demonstrated that, with
the use of a very limited set of distance constraints obtained
from a protein that is fully deuterated with the exception of
the methyl groups of Val, Leu, and Ile, a high-quality deter-
mination of the fold of the protein can be obtained [17–19].
We have labeled the Runt domain in this manner to assist
in the determination of the fold of the protein. Assignment
of the methyl resonances of the protein were obtained from
HCCCONNH and CCCONNH total correlation spec-
troscopy (TOCSY) experiments [20] recorded at 500 MHz.
Because of the poor dispersion of the methyl resonances
(90% of the methyl 1H δs within 0.25 ppm and 95% of all
13C δs within 6.0 ppm), subsequent NOESY data for struc-
ture determination were collected at 800 MHz. 15N- and
13C-edited 3D NOESY spectra were recorded at 800 MHz
with a mixing time of 180 ms for collection of distance con-
straints. CA, CB, and CO assignments for the 100% deuter-
ated protein were corrected for the effects of the 2H on the
chemical shifts of CA and CB as described previously [18].
These values were used in the program TALOS to derive
dihedral-angle restraints for phi and psi angles as described
previously [21]. 
On the basis of a total of 227 useful distance constraints
derived from the NOESY data and 80 dihedral angle
restraints derived from TALOS (Table 1), we have cal-
culated the fold of the Runt domain using DYANA v1.5.
In addition, a total of 12 hydrogen-bond restraints were
employed for residues that met the following criteria:
TALOS predicted a β conformation, appropriate inter-
strand NOEs were observed, slowed NH exchange was
observed, and they were not located at the
ends of β-strand elements. Subsequently, the conform-
ers were subjected to energy minimization with the
program OPAL.
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Backbone fold of the CBFA2 Runt domain
Figure 1 shows a stereoview of ten conformers represent-
ing the fold of the Runt domain obtained from these data.
Only residues 21–135 are displayed because no long-range
NOEs were observed in our data for residues 1–22 at the
N terminus or for residues 131–174 at the C terminus.
Residues 11–14 at the N terminus did display strong
sequential dNN NOEs indicative of a local helical or turn
conformation for this region, but no long-range NOEs were
observed for these residues. These C-terminal and N-ter-
minal regions displayed decreased linewidth and a lack of
NOEs, consistent with their being mobile in solution. The
basis for such a long, apparently flexible C-terminal tail
contributing to increased solubility is not clear at this point.
There are seven clearly discernible β strands in the struc-
ture of the Runt domain (Figure 2) comprised from the fol-
lowing residues: 31–33 (β1), 50–53 (β2), 61–64 (β3), 81–83
(β4), 88–90 (β5), 108–111 (β6) and 118–121 (β7). As we
have not obtained resonance assignments for R124, the
exact length of the C-terminal strand may be longer than
observed thus far in our structure calculations. Strands 1, 2,
and 5 combine to form one antiparallel β sheet and strands
3, 4, 6, and 7 combine to form a second antiparallel β sheet.
The two sheets are packed on one another at a shallow
angle to yield a β-sandwich arrangement. No other regular
secondary structural elements were consistently identified
in the structure, in agreement with previous CD measure-
ments [13] which indicated that the domain contained only
extended elements of regular secondary structure. Strong
sequential dNN NOEs were observed for residues 69–75 of
the loop connecting strand 3 to strand 4; however, neither
TALOS nor the subsequent structure calculations identi-
fied this region as being α-helical. The various strands are
connected by a series of loops of varying length and com-
position. Because of the antiparallel nature of the β strands,
these loops alternate along the sequence between the top
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Figure 1
Stereoview of the ensemble of ten energy-
minimized conformers representing the
solution structure of the CBFA Runt domain.
Residues 20–135 are shown. The backbone
atoms corresponding to the s-type Ig fold are
colored in cyan, loops connecting β1–β2,
β2–β3, β3–β4, β4–β5, β5–β6, β6–β7 are
colored in green, magenta, yellow, blue, red
and orange, respectively.
Structure
Table 1
Experimental constraints and structure calculations.
NMR constraints 
Distance constraints (total / long range)
Total non-redundant NOE constraints 227 / 164
NH–NH 145 / 112
NH/CH3–CH3 82 / 52
Angle constraints
Phi 40
Psi 40
Hydrogen bonds 12
Energy minimization
AMBER energy (Kcal mol–1) –1137 ± 411
Residual distance violations
Sum (Å) 16.1 ± 0.6
Maximum (Å) 0.4 ± 0.01
Residual angle violations
Sum (°) 55.2 ± 5.7
Maximum (°) 5.0 ± 0.03
Structure statistics*
All backbone atoms (Å) 2.14
Heavy atoms in all regular secondary structure (Å) 1.34
Backbone atoms in regular secondary structure (Å) 0.63
Backbone atoms in β1, β2, β5 (Å) 0.43
Backbone atoms in β3, β4, β6, β7 (Å) 0.41
*Rmsd to the mean of residues 20–135 in the ten lowest energy
conformers.
and bottom of the protein. This results in two groups of
loops, located at the top and bottom of the structure as
depicted in Figure 2. Interestingly, there are several strong
inter-loop long-range interactions present in the structure
that are likely to be of functional significance. There is a
short two-stranded antiparallel β sheet involving residues
Leu77/Arg78–Arg95/Phe96 and a short two-stranded paral-
lel β sheet involving residues Ile128/Thr129–His38/Trp39,
both located at the top of the structure as depicted in
Figure 2.
The core β-sheet region is quite well defined, with an
overall root mean square deviation (rmsd) to the mean of
0.63 Å for the backbone of residues comprising the two
β sheets (Table 1). The quality of the structure for this
portion of the protein compares quite favorably with struc-
tures obtained from much denser sets of constraints and
provides a meaningful framework for interpretation of the
biological function of the domain. The rmsd for the entire
backbone of all residues depicted in Figure 1 is 2.1 Å,
demonstrating that the loop regions are not nearly as well
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Figure 2
S-type Ig fold of the Runt domain. (a) Ribbon
representation (left) of the minimum-energy
conformer and topology representation (right)
of the Runt-domain structure. Consistent
β-sheet regions are colored in cyan and
connecting loops are in gray. The short
β-sheet regions mentioned in the text are
indicated in their respective loops. (b) Ribbon
representation (left) and topology diagram
(right) of a fibronectin domain. (c) Topological
representation of the s-type Ig fold. Strands
are labeled as described by Bork et. al. [22]
defined. This is to be expected on the basis of the lack of
long-range NOE or dihedral-angle restraints for these por-
tions of the structure. The lack of definition in these regions
means that their overall location is defined; however, details
of their relative positions cannot be considered. 
Discussion
The Runt domain displays an immunoglobulin fold
Examination of the structure of the Runt domain
(Figure 2) shows that it clearly has the classic immunoglob-
ulin (Ig) fold consisting of two antiparallel β sheets with a
total of seven to nine strands packed on one another at a
small angle, with the connections between the strands pro-
vided by varying loop regions. Despite their structural sim-
ilarity, Ig domains typically do not display high identity to
one another at the primary sequence level, explaining why
the primary sequence of the Runt domain did not exhibit
any obvious homology to other proteins. Bork et al. [22]
have subdivided the folds of Ig domains observed in
protein structures into four classes on the basis of β-sheet
and loop topology. On the basis of this analysis, the Runt
domain falls into the s-type Ig fold, which is perhaps best
exemplified by the structure of the fibronectin repeat
element. Indeed, a Dali [23] search yielded fibronectin as
one of the proteins with the highest degree of structural
homology to the Runt domain. The β-sheet and loop
topology of fibronectin and the Runt domain are illustrated
in Figure 2, which also gives a ribbon representation of the
two proteins and the s-type Ig fold, illustrating the high
degree of structural similarity. As mentioned by Bork et al.,
the outer strands in the sheets and especially the loops are
conformationally flexible and can be relocated in different
families without perturbing the core Ig structure. 
The Runt domain is a member of a family of s-type Ig-fold
DNA-binding proteins
A number of DNA-binding proteins possessing Ig folds,
including NF-κB, NFAT, p53, STAT-1 and the T
domain, have recently been structurally characterized
[24–28]. Strikingly, all of these proteins share the s-type
core Ig fold observed in the Runt domain. This is illus-
trated definitively in Figure 3, where both ribbon and
schematic representations of the folds of all the relevant
domains of these proteins are shown. The differences
among these proteins arise in the connecting loop regions
where short additional secondary structural elements have
been added that in some cases interact with the core Ig
scaffold. As the edges of the β sheets have been shown to
be consistent sites of alteration in the Ig fold [22] and
loops are readily modified over time to alter function, this
similarity may imply an evolutionary relationship among
these proteins. They could all have evolved readily from a
common ancestor having a core Ig fold by loop modifica-
tions and gene duplication. For these reasons, these pro-
teins define a family of structurally related DNA-binding
domains. In all five cases, these proteins regulate very
critical cellular functions; it would therefore appear that
this family has been utilized for very specialized critical
roles in transcriptional regulation. 
The fold of the Runt domain shows a strong resemblance
to that of the recently solved STAT-1 [27] protein in par-
ticular (Figure 3). In addition to the shared s-type Ig fold
of STAT-1, several structural subtleties are also con-
served between these two proteins. As seen in Figure 3,
STAT-1 has a short β-sheet interaction involving strands
in L1 and the region C-terminal to the Ig fold that is
structurally homologous to the short β-sheet interaction
between His38/Trp39 and Ile128/Thr129 observed in the
Runt domain. In addition, there is another short β-sheet
interaction involving strands in loops L3 and L5 in
STAT-1 that is structurally homologous to the β-sheet
interaction in the Runt domain between Leu77/Arg78
and Arg95/Phe96.
Location of the DNA-binding site in the Runt domain and
related proteins
Previous mutagenesis studies [10,29] have provided identi-
fication of a number of residues that are critical for DNA
binding by the Runt domain. Figure 4 shows those amino
acids that have been shown by mutagenesis to be impor-
tant for DNA binding. We have recorded 15N-edited
NOESY spectra on samples of fully deuterated Runt
domain complexed to unlabeled DNA to identify back-
bone NHs with NOEs to the DNA. 15N half-filtered 3D
NOESY data have also been recorded to distinguish
protein–protein from protein–DNA NOEs. Those residues
displaying intermolecular NOEs are also indicated in
Figure 4. All of the loop regions in the Runt domain are
implicated by mutagenesis or NOE data to be involved in
DNA binding. Loop L5 connecting βE and βF in the Runt
domain (Figure 3) is the location of the P-loop element
that has been shown by mutagenesis to be critical for DNA
binding. We also observe NOEs to the DNA in this loop,
confirming its close proximity to the DNA. Loop L6 con-
necting strands βF and βG (Figure 3) shows very strong
NOEs to the DNA and also contains a novel primary
sequence of VFTNPPQ (single-letter amino acid code)
containing two sequential prolines. The intimate contact
observed between this region of the Runt domain and
DNA is consistent with the known importance of
proline–aromatic interactions in protein–ligand recogni-
tion, for example in the recognition of proline-containing
peptides by SH3 (Src-homology 3) domains. 
DNA binding is mediated by the loops between the
β strands of the Ig scaffold, as has also been seen for
NF-κB, p53, NFAT, STAT-1, and the T-domain. Unlike
these other proteins, where the DNA-binding loops in
each of the Ig domains are located spatially at one end of
each domain, loops at both ends of the Runt domain are
involved in binding to DNA (Figures 3,4). In contrast to
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the other proteins of this family, the Runt domain has
been shown to substantially bend DNA [30]. This
bending may require contacts at both ends of the Ig fold.
There is a similarity in the location of the loops utilized
for DNA binding among the proteins of this family. In all
cases except the C-terminal domain of NF-κB (referred to
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as domain 2 in Figure 3), the loops labeled L1 and L5,
located at the top of the Ig core, participate in DNA
binding. In addition, elements C-terminal to the Ig fold,
also located at the top of the core, are involved in DNA
binding in all of these cases. The Runt domain and the
T-domain also employ the L3 loop for mediating DNA
contacts. As mentioned above, the Runt domain employs
loops at both ends of the protein for DNA binding, unlike
all of the other members of this family. Loops L2 and L4
located at the bottom of the fold, as illustrated in Figure 3,
are used for DNA binding by the Runt domain, as is also
seen for the C-terminal domain of NF-κB but for no other
member of this family.
Binding to CBFB
CBFB has been shown to be essential for the in vivo func-
tion of CBFA2 [8]. Previous studies have shown that
CBFB enhances the DNA-binding affinity of the isolated
Runt domain approximately sixfold and that binding is
accompanied by a conformational change in one or both
proteins (Crute et. al., unpublished results). In the context
of the full-length protein CBFB has been shown to relieve
inhibition mediated by sequences C-terminal to the
domain, resulting in up to a 40-fold enhancement in DNA
binding [31] (T-L Gu, TL Goetz, BJ Graves and NAS,
unpublished results). Mutations in the Runt domain that
affect CBFB binding are shown in Figure 4. There is a
cluster of mutations involving residues 66–69, 106, and
108 that have been shown to affect CBFB binding to
CBFA, suggesting that this region is critical for interaction
with CBFB. The recently solved structure of CBFB [11]
identified a moderate-sized interaction surface for binding
with the Runt domain, in agreement with binding via a
limited region of the Runt domain. A mutation in Q118,
located at the other end of the fold, was also shown to
affect CBFB binding. Whether this is a direct contact or
causes a perturbation in the structure cannot be deter-
mined at this time. Interestingly, this putative
CBFB-binding region is spatially proximal to residues
shown to be involved in DNA binding, thus providing a
rationale for the effect of CBFB on the DNA-binding
affinity of the Runt domain. Consistent with this we have
observed substantial changes in the NMR spectra of the
Runt domain upon binding of CBFB, particularly for a
number of residues in close proximity to the DNA (J Yan
and JHB, unpublished results). These data agree with a
model in which CBFB induces a conformational change in
CBFA that increases its affinity for the DNA. These data
also provide an explanation for the ability of CBFB to
release inhibited forms of full-length CBFA — the
inhibitory domain must contact the DNA-binding region
on the top of the structure, as illustrated in Figure 2. The
binding of CBFB would disrupt this interaction and
expose the proximal loops for DNA binding. Interestingly,
Research Article  Ig fold of CBFA Runt domain Berardi et al. 1253
Figure 4
Schematic representation of the intermolecular
contacts of the CBFA Runt domain. The red
spheres correspond to the spatial location in
CBFA of intermolecular protein (NH)–DNA
NOEs observed in a CBFA–DNA complex in
which the DNA is protonated and all the
nonexchangeable protons in CBFA are
deuterated. Known point mutations that affect
DNA binding and CBFB binding are shown as
blue and gray spheres, respectively. 
Figure 3
Comparison of six topologically similar transcription factor DNA-
binding domains from (a–g) CBFA, STAT-1, T-domain, NFAT
(C-terminal Ig domain), NFκB N-terminal domain, p53, and NFκB
C-terminal domain. The ribbon representations of each protein shown
on the left in each panel (CBFA in stereo) were produced using the
DNA-binding domains extracted from the corresponding protein–DNA
complexes. A topological map of each protein is shown on the right in
each panel. The conserved β-sheet core of the s-type Ig fold is colored
in cyan. The locations of protein–DNA contacts are indicated with
arrows. Protein–DNA contacts were obtained from the NOESY
information on the CBFA complex and extracted from PDB coordinates
with database entries 1bf5, 1xbr, 1a66, 1vkx, and 1tsr for the other
proteins, respectively.
this site predicted to be involved in CBFB interaction on
the Runt domain is at a spatial location in NFAT where
interactions with AP-1 have been shown to occur [32]. 
Biological implications
Core binding factor (CBF) has been shown to be critical
for hematopoietic development. CBF is comprised of a
DNA-binding CBFA subunit and a non-DNA-binding
CBFB subunit. Both proteins have been shown to be
essential for function in hematopoiesis. CBFB has been
shown to modulate the DNA-binding affinity of CBFA,
but it does not seem to contact the DNA directly. Chro-
mosomal translocations involving CBF genes have been
shown to be the most common genetic abnormality iden-
tified in leukemia patients. The two proteins of this novel
transcriptional enhancer have not been structurally
chracterized previously. We have recently solved the
structure of the CBFB protein. In this paper we describe
the structural characterization of the DNA and CBFB-
binding domain, the Runt domain, of the CBFA subunit. 
Using NMR spectroscopy we have determined that the
CBFA Runt domain possesses an s-type immunoglobu-
lin (Ig) fold. This core fold of the Runt domain was
shown to be conserved in the Ig folds found in the DNA-
binding domains of NFAT, p53, NF-κB, STAT-1, and
the T-domain. The structural and functional similarity
among these proteins indicates that the DNA-binding
domains of these proteins form a family of structurally
and functionally-related proteins. The determinants for
DNA binding on the Runt domain have been mapped
from a combination of intermolecular NOEs and muta-
genesis data showing that DNA binding is mediated via
the loop regions of the Ig fold, as is seen for the other
members of this family. Unlike the other members of
this family, the Runt domain was shown to be unique in
employing loops at both ends of the Ig fold for DNA
binding. There are clear similarities in the use of the
loop regions for DNA binding that support the related-
ness of these proteins. Interaction with CBFB has been
mapped using previous mutagenesis results to a specific
location on the structure whose proximity to protein ele-
ments involved in DNA binding provides an explanation
for CBFB’s ability to modulate the DNA-binding
affinity of the Runt domain. These structural studies in
conjunction with our recent determination of the struc-
ture of the CBFB protein provide a detailed molecular
characterization of the two proteins of this critical
transcription factor.
Materials and methods
Sample preparation for backbone resonance assignment
CBFA2(41–214) was expressed and purified according to the proce-
dure described by Crute et al. [13]. Celtone media (Martek, Inc.) was
employed for preparation of the 50% 2H, 98% 13C/15N sample. Bio-
Express media (Cambridge Isotopes) was employed for the prepara-
tion of the 100% 2H, 98% 13C/15N sample. Following purification as
described previously [13], the protein was complexed to an 18 base
pair DNA duplex of sequence containing a high-affinity core site and
further purified by size-exclusion chromatography on a Sephacryl
S-100 column. The final buffer employed for NMR measurements con-
sisted of 10 mM potassium phosphate (pH 6.0), 1 µM EDTA, 1 mg/ml
sodium azide, 1 µM thioredoxin, and 4 mM DTT. All samples were
purged with argon prior to recording of the NMR data. A final concen-
tration of 0.5 mM, or less, of Runt domain–DNA complex was used in
all measurements.
Samples of CBFA2(41–214) specifically labeled with 15N in specific
amino acids were prepared by transformation into auxotrophic strains
described elsewhere [16] and growth of cells in rich media employing
specific 15N-labeled amino acids. The protein was purified as
described above. Runt domain–DNA complexes with amino-acid-spe-
cific labeling in the following amino acids were prepared: Ala, Arg, Cys,
His, Ile, Leu, Lys, Phe, Thr, Trp, Tyr, and Val.
Preparation of a 15N, 13C, 2H (1H-methyl Leu, Val,
1Hδ1-methyl Ile) sample
The procedure of Gardner and Kay [19] was followed, with some
modifications. A fresh transformation of CBFA2(41–214) plasmid
DNA into BL21 DE3 pLysS cells was made and the cells were inocu-
lated directly onto a 50% D2O minimal plate containing 4 g l–1 of
glucose and 100 µg ml–1 of carbenicillin. Colonies (2 mm) were
obtained after 12 h incubation at 37°C. These colonies were then
transferred to ~100% D2O plates containing 4 g l–1 glucose and incu-
bated for 24–30 h at 37°C. The colonies adapted to the D2O media
were transferred to 50 ml of 100% D2O containing 0.75 g l–1 2H,
13C-glucose and the culture diluted 1:5 in fresh media when the
OD600 reached 0.1 +/– 0.01 units (about 14 h). The diluted culture
was grown to OD600 = 0.25, at which point an additional 0.75 g l–1 of
2H, 13C-glucose was added along with 50 mg l–1 of 15N, 13C-valine
and 55 mg l–1 of (3,3-2H2) 13C 2-ketobutyrate (Na+ salt). At this time,
the culture was also induced with 0.8 mM isopropyl-β-D-thiogalacto-
side (IPTG) and incubated for an additional 20 h. The protein was
purified and the DNA complex prepared as described above.
NMR spectroscopy for backbone resonance assignment and
mapping of the DNA-binding site
NMR measurements were carried out at 40°C on a Varian Inova
500 MHz NMR spectrometer equipped with an actively shielded triple-
resonance probe (Nalorac Corporation) and pulsed-field gradients, and
on a Bruker DRX 750 MHz NMR spectrometer at the NMRFAM.
Pulsed-field gradients were utilized for suppression of the water signal
and undesired coherence pathways. NMR data were processed with
the program PROSA and the resulting NMR data were visualized and
analyzed using the program XEASY.
For backbone resonance assignment, HNCACB, HN(CO)CACB,
HN(CA)CO, and 15N-edited NOESY spectra were recorded on a
sample of 50% 2H/98% 13C,15N-labeled Runt domain–DNA using the
15N–1H reverse INEPT element derived from the FHSQC experiment
on a 750 MHz Bruker DRX spectrometer located at the NMRFAM.
Gradient sensitivity-enhanced 15N–1H HSQC spectra of all of the
specifically labeled samples were recorded at 500 MHz on a Varian
Inova spectrometer. HNCA, HN(CA)CB, and HNCO spectra were
recorded on a sample of 98% 2H,13C,15N-labeled Runt domain–DNA
at 500 MHz on a Varian Inova spectrometer. 
For purposes of mapping of the DNA-binding site, 15N-edited NOESY
spectra were recorded on the 98% 2H,13C,15N-labeled Runt
domain–DNA at 800 MHz and an ω2-15N-half-filtered 3D 15N-edited
NOESY at 500 MHz. 1H and 13C assignments for the methyl sub-
stituents were obtained from CCCONNH and HCCCONNH TOCSY
data recorded at 500 MHz on a Varian Unity Inova spectrometer on the
15N,13C,2H-(1H-methyl Leu, Val, 1Hδ1-methyl Ile) Runt domain–DNA
sample. 15N-edited and 13C-edited NOESY data were collected at
800 MHz on a Bruker DRX spectrometer with a mixing time of 180 ms.
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Structure calculations
The N, CA, CB, and CO chemical shifts from the fully deuterated Runt
domain were corrected for deuteration as described previously [18] and
utilized as input for the program TALOS to generate chemical-shift-based
dihedral-angle restraints for φ and ψ angles. The fold was calculated on
the basis of a total of 227 useful distance constraints derived from the
NOESY data and 80 angle constraints derived from TALOS. The back-
bone bone φ and ψ angles angle restraints were created by using a 60°
window on the predicted angles. In addition, a total of 12 hydrogen-bond
restraints were employed for residues in which all the following condi-
tions were met simultaneously: appropriate strong interstrand NOEs
were observed, slowed NH exchange was observed, TALOS predicted
angles in a conformation that falls within a 60° window centered on the
ideal β-sheet values, and they were not located at the ends of the 
β-strand elements in a previously calculated structure. NH–NH and NH-
methyl NOE crosspeak intensities obtained from the deuterated samples
were converted to distance constraints iteratively using dmin = 2.6 Å,
dave = 3.6 Å and dmax = 6 Å. Structure calculations were performed with
DYANA 1.5. A total of 160 random structures were generated and sub-
jected to one cycle of 4000 steps of heating and 6000 steps of anneal-
ing followed by 1000 steps of conjugate gradient minimization. The
error-tolerant target function β2/2((1+(D2–b2)/βb2)0.5–1) was used
during the distance-constraint calibration and switched to the more
restrictive target function ((D2–b2)/2b)2, in which D is the actual distance,
b is the bound and β is a parameter that weights the sensitivity of the
target function distance violations. From 160 minimized structures, the
20 lowest target function structures were selected. The 20 DYANA
structures were refined using the program OPAL v2.6. The refinement
was performed as follows. The structures were first subjected to
restrained energy minimization using the hydrogen bond and experimen-
tal NMR distance and angle restraints. The electrostatic contributions
were underweighted by using a dielectric constant of 20 D. 1–4 van der
Waals interactions were weighted to 1.0. The AMBER94 force field was
used and terms for van der Waals, electrostatic, bond, bond angle, dihe-
dral angle, improper dihedral angle and experimental constraint energies
were evaluated. After the initial minimization, the conformers were heated
to 300K and subjected to a 2 ps constrained molecular dynamics simula-
tion. The experimental violation energies were set to 0.1 kT/2 kcal mol–1
at room temperature for a 0.25 Å distance or 5.0° angle violation during
the minimization step and 2.0 Å distance or 30.0° angle violations during
the molecular dynamics simulation. The final 1000 steps of minimization
were performed after energy minimization, using the same energy para-
meters as above. The ten lowest energy conformers were selected to
represent the fold of the Runt domain. The minimized structures were
fitted to the mean structure and all figures were prepared using the
program MOLMOL v2.6. 
Accession numbers
The coordinates for the fold of the Runt domain have been deposited in
the Protein Data Bank under accession code 1co1.
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